In this study we have pinpointed the collagen receptor Endo180 as a novel modulator of rounded tumor cell migration in the context of the bone (osteoblast-derived ECM) and visceral tissue (fibroblast-derived ECM) microenvironments. Here, ITGA2 is linked to neoplasm.